Shares of CASI Pharmaceuticals, Inc. (CASI) ended the day up 40%, after the company announced that it had received Orphan Drug Designation from the European Union for its liver cancer drug. The drug from the company which treats hepatocellular carcinoma – liver cancer – is known as ENMD-2076. In addition to receiving Orphan Drug designation…
Video Length: 00:12:31 On August 26, I made a video report explaining why this correction would evolve to look a lot like the 2011 two-month event. That “roadmap” has turned out to be very accurate. I advised then for investors to be ready to “buy the recession fear” anywhere near S&P 1800. So far in…
Following more than a year in which Netflix pulled an Amazon quite successfully, burning through tens then hundreds of millions in cash but promising ever loftier growth, moments ago the magic finally ended, when Reed Hastings’ company reported Q3 revenue of of $1.581 billion, wildly missing not only consensus expectations of $1.75 billion, but its…
Quantitative study of the markets has become incredibly popular over the past few years. Looking at specific, technical stock market events and then backtesting to see how the market performed after similar events in the past has become the pastime of many a market watcher. And it’s valuable stuff. But the real value is in…
Several US announcements During the day on Thursday, all of the economic announcements worth paying attention to will be out of the United States, so therefore think it will be a very US centric day. The US dollar seems to be on its back foot, so we believe that this could be a very interesting…
Walmart is leading the Dow Jones average lower today as the company announces a decrease to it’s 2015 sales outlook and warns of future sales and earnings declines to come. Down almost 9% today, it’s one of the worst days in 20 years for the stock. Click on image to enlarge From a purely technical…
Walmart is leading the Dow Jones average lower today as the company announces a decrease to it’s 2015 sales outlook and warns of future sales and earnings declines to come. Down almost 9% today, it’s one of the worst days in 20 years for the stock. Click on image to enlarge From a purely technical…
This is the second in an occasional series on how the most successful early investors build their portfolios. And, of course, our take. Upfront Ventures has its own ways of doing things. Fortunately, its managing partner, Mark Suster, has a blog. So we can get a very good idea of how Mark – and, through him,…
Wal-Mart (WMT) announced flat year-over-year sales, causing its shares to fall by 9% and wiping $20 billion from its market cap. Which would be unremarkable if the disappointment was an aberration. But it’s not. Earnings season is off to a brutal start, with big names announcing big misses all over the place. Meanwhile, the rare good numbers…
A wise man will make more opportunities than he finds. – Francis Bacon The press is giving too much credence to the effect an interest rate hike could/would have on the markets and on the financial sector. First of all, the fact that the Fed has been debating whether or not to raise rates by a…
